This result aligned with the study conducted by Dam and co-workers, where Aptamer-loaded gold nanostars treated cervical cancer cells, demonstrated increased caspase 3/7 activity and induction of apoptosis (64). This evidence concerns the gene CASP3 and cervical carcinoma.